Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.

Diabetologia · 2021 · PMC8012337 · PMID 33687487

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

approaching significancep = 0.054so close (0.05 < p ≤ 0.1)

The reduction in 2 h PPG was significantly higher in the 150 μg and 200 μg PB-119 groups compared with the placebo group ( p < 0.001) and approaching significance in the 75 μg PB-119 group ( p = 0.054).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.